XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]        
Net revenue $ 150,658 $ 153,052 $ 435,597 $ 427,289
Cost of revenue [1] 136,567 132,665 393,626 375,334
Gross profit 14,091 20,387 41,971 51,955
Operating expenses:        
Product development [1] 5,509 4,905 14,995 14,776
Sales and marketing [1] 2,033 2,768 7,773 8,303
General and administrative [1] 5,489 6,460 21,758 19,931
Operating income (loss) 1,060 6,254 (2,555) 8,945
Interest income 7 5 7 40
Interest expense (277) (301) (817) (947)
Other income (expense), net 45 (28) 51 16,695
Income (loss) before income taxes 835 5,930 (3,314) 24,733
Benefit from (provision for) income taxes 1,395 (893) 3,009 (4,549)
Net income (loss) $ 2,230 $ 5,037 $ (305) $ 20,184
Net income (loss) per share:        
Basic $ 0.04 $ 0.09 $ (0.01) $ 0.38
Diluted [2] $ 0.04 $ 0.09 $ (0.01) $ 0.37
Weighted-average shares used in computing net income (loss) per share:        
Basic 54,645 53,427 54,339 52,988
Diluted 55,536 55,623 54,339 55,015
[1]

Cost of revenue and operating expenses include stock-based compensation expense as follows:
[2] Diluted net loss per share for the nine months ended March 31, 2022 does not reflect any potential common stock relating to stock options, restricted stock units, or shares issuable related to the ESPP due to net losses incurred. The assumed issuance of any additional shares would be anti-dilutive